AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Hailemariam, S Walder, M Burger, HR Cathomas, G Mihatsch, M Binswanger, U Ambuhl, PM
Citation: S. Hailemariam et al., Renal pathology and premortem clinical presentation of Caucasian patients with AIDS: An autopsy study from the era prior to antiretroviral therapy, SWISS MED W, 131(27-28), 2001, pp. 412-417

Authors: Weinreich, T Wuthrich, RP Booy, C Binswanger, U
Citation: T. Weinreich et al., Suppression of ICAM-1 expression in renal proximal tubular cells by 1,25-dihydroxyvitamin D-3, KIDNEY BL P, 24(2), 2001, pp. 92-98

Authors: Hofbauer, GFL Dummer, R Hafner, J Burg, G Binswanger, U Kempf, W
Citation: Gfl. Hofbauer et al., Skin cancers in organ transplant recipients: Two cases of virus-induced neoplasms, DERMATOLOGY, 202(4), 2001, pp. 359-361

Authors: Wuthrich, RP Cicvara, S Ambuhl, PM Binswanger, U
Citation: Rp. Wuthrich et al., Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation, NEPH DIAL T, 15(8), 2000, pp. 1228-1231

Authors: Wuthrich, RP Cicvara, S Booy, C Widmer, U Binswanger, U
Citation: Rp. Wuthrich et al., The 825C/T polymorphism of the G-protein subunit beta 3 does not influenceblood pressure and renal function in kidney transplant recipients, NEPH DIAL T, 15(10), 2000, pp. 1663-1666

Authors: Gruter, E Romero, J Grussner, R Binswanger, U
Citation: E. Gruter et al., Extraintestinal salmonellosis after kidney allotransplantation, SCHW MED WO, 130(6), 2000, pp. 186-189

Authors: Ambuhl, PM Binswanger, U Renner, EL
Citation: Pm. Ambuhl et al., Epidemiology of chronic hepatitis B and C among dialysis patients in Switzerland, SCHW MED WO, 130(10), 2000, pp. 341-348

Authors: Weinreich, T Landolt, M Booy, C Wuthrich, RP Binswanger, U
Citation: T. Weinreich et al., 1,25-dihydroxyvitamin D-3 stimulates transforming growth factor-beta 1 synthesis by mouse renal proximal tubular cells, KIDNEY BL P, 22(3), 1999, pp. 99-105

Authors: Wuthrich, RP Weinreich, T Ambuhl, PM Schwarzkopf, AK Candinas, D Binswanger, U
Citation: Rp. Wuthrich et al., Reduced kidney transplant rejection rate and pharmacoeconomic advantage ofmycophenolate mofetil, NEPH DIAL T, 14(2), 1999, pp. 394-399

Authors: Ambuhl, PA Muller, V Binswanger, U
Citation: Pa. Ambuhl et al., Transient proteinuria after infusion of a gelatin plasma volume expander, CLIN NEPHR, 52(6), 1999, pp. 399-400

Authors: Ambuhl, PM Meier, D Wolf, B Dydak, U Boesiger, P Binswanger, U
Citation: Pm. Ambuhl et al., Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: Impact on muscular phosphate content, mineral metabolism and acid/base homeostasis, AM J KIDNEY, 34(5), 1999, pp. 875-883

Authors: Senn, B Rochat, P Schwarzkopf, AK Weinreich, T Binswanger, U
Citation: B. Senn et al., Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction, TRANSPLAN P, 30(8), 1998, pp. 4075-4076

Authors: Wuthrich, RP Weinreich, T Schwarzkopf, AK Candinas, D Binswanger, U
Citation: Rp. Wuthrich et al., Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation, TRANSPLAN P, 30(8), 1998, pp. 4096-4097
Risultati: 1-13 |